Latest Balance Sheet News

SSH Group Ltd has reported a remarkable turnaround in its half-year results, with revenue climbing 25% and net profit soaring over 3300%, driven by strong mining sector activity and operational efficiencies.

Fleetwood Limited reported a 16% decline in revenue for the half-year ended December 2025 but posted an 84% jump in net profit, driven by strong occupancy in its Community Solutions segment and strategic asset sales.

NextEd Group Limited reported a 16.7% rise in underlying EBITDA and a 92% reduction in NPAT loss for H1 FY26, underpinned by AI integration and a strategic shift to higher-margin education segments.

Imricor Medical Systems saw a sharp 69.5% decline in revenue for 2025, driven by clinical trial impacts, yet narrowed its net loss to $25.3 million as it secured FDA clearance for key products post-year-end.

Meridian Energy has reported a robust turnaround with a NZD 227 million net profit after tax for the first half of 2026, driven by record wind generation and strong hydro inflows. The company also raised its interim dividend and advanced multiple renewable projects.

Tian An Australia Limited reported a remarkable turnaround in FY2025, posting a statutory profit of $23.4 million on $84 million revenue, driven by the completion of The Henley, Enfield project and a significant gain from debt restructuring.

Magontec Limited reported a net loss of $5.4 million for 2025 on a 10.9% drop in revenue, yet net tangible assets per share rose significantly to 76 cents.

Bapcor Limited has postponed its half-year financial results release to no later than 27 February 2026 and is seeking an extension of its trading suspension, hinting at a potential capital raising.

Steadfast Group Limited reported a solid half-year result for December 2025, with underlying net profit after tax rising 7% to $137.5 million and a fully franked interim dividend declared. The insurer intermediary also increased its gearing capacity to support ongoing growth.

Prescient Therapeutics reported a 62.8% increase in half-year losses to nearly $4 million, driven by intensified clinical development of its PTX-100 cancer therapy. The company bolstered its balance sheet with a $9.85 million capital raise while securing key regulatory milestones in Europe and the US.

Wagners Holding Company Limited has reported a robust half-year result for December 2025, with revenue climbing to $251.7 million and net profit after tax soaring 70% to $21 million. Improved margins and operational efficiencies across key segments underpin the strong performance.

Nuchev Limited reported a 12% increase in revenue to $12.38 million for the half-year ended December 2025, driven by growth in core products and offshore markets. However, the company’s net loss widened to $2.34 million amid ongoing investments in marketing, product development, and international expansion.